Towards the introduction of the 'Immunoscore'in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell… - The Journal of …, 2014 - Wiley Online Library
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine …
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine …
Escape of human solid tumors from T–cell recognition: Molecular mechanisms and functional significance
FM Marincola, EM Jaffee, DJ Hicklin, S Ferrone - Advances in immunology, 1999 - Elsevier
Publisher Summary It is known for some time that malignant transformation of human cells
may be associated with the appearance of tumor associated antigens (TAA). Decades of …
may be associated with the appearance of tumor associated antigens (TAA). Decades of …
[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell… - Journal of translational …, 2012 - Springer
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
SA Rosenberg, JC Yang, DJ Schwartzentruber… - Nature medicine, 1998 - nature.com
The cloning of the genes encoding cancer antigens has opened new possibilities for the
treatment of patients with cancer. In this study, immunodominant peptides from the gp100 …
treatment of patients with cancer. In this study, immunodominant peptides from the gp100 …
A human memory T cell subset with stem cell–like properties
Immunological memory is thought to depend on a stem cell–like, self-renewing population of
lymphocytes capable of differentiating into effector cells in response to antigen re-exposure …
lymphocytes capable of differentiating into effector cells in response to antigen re-exposure …
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …
improved. A robust immune score quantification is needed to introduce immune parameters …
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment
The gut microbiota influences both local and systemic inflammation. Inflammation
contributes to development, progression, and treatment of cancer, but it remains unclear …
contributes to development, progression, and treatment of cancer, but it remains unclear …
HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
SA Migueles, MS Sabbaghian… - Proceedings of the …, 2000 - National Acad Sciences
A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4+ T cell
counts and< 50 copies/ml of plasma were prospectively recruited for study. HLA typing …
counts and< 50 copies/ml of plasma were prospectively recruited for study. HLA typing …
[HTML][HTML] gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
DJ Schwartzentruber, DH Lawson… - … England Journal of …, 2011 - Mass Medical Soc
Background Stimulating an immune response against cancer with the use of vaccines
remains a challenge. We hypothesized that combining a melanoma vaccine with interleukin …
remains a challenge. We hypothesized that combining a melanoma vaccine with interleukin …
[HTML][HTML] The role of BRAF V600 mutation in melanoma
PA Ascierto, JM Kirkwood, JJ Grob, E Simeone… - Journal of translational …, 2012 - Springer
BRAF is a serine/threonine protein kinase activating the MAP kinase/ERK-signaling
pathway. About 50% of melanomas harbors activating BRAF mutations (over 90% V600E) …
pathway. About 50% of melanomas harbors activating BRAF mutations (over 90% V600E) …